NEVIRAPIN Viatris cpr ret 400 mg 30 pce
7680667650027
CH-66765
J05AG01
08.03.0.
1 / 3
google
Details
- Product number
- 6676501
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- nevirapinum 400 mg, lactosum monohydricum 398 mg, hypromellosum, natrii stearylis fumaras, pro compresso corresp. natrium 710 µg.
Articles (1)
Nevirapin Viatris 400 mg, Retardtabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
398.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
710.0 UG | Substance | HBESI |
Reimbursement information
Public price
CHF 193.35
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2018
Authorization holder
Viatris Pharma GmbH
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 66765
- Drug name
- Nevirapin Viatris, Retardtabletten
- Galenic form
- RETT
- ATC Code
- J05AG01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 12/09/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NEVIRAPIN Viatris cpr ret 400 mg 30 pce
- Description (DE)
- NEVIRAPIN Viatris Ret Tabl 400 mg 30 Stk
- Market launch
- 12/09/2018
- Narcotic (BTM)
- No